Back to Journals » OncoTargets and Therapy » Volume 10

Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant

Total article views   Abstract views HTML views PDF downloads Totals
3,597 Dovepress* 3,077 337+ 602 3,414
PubMed Central* 0 183 62 183
Totals 3,077 520 664 3,597
*Since 21 August 2017
+Since July 2016

View citations on PubMed Central and Google Scholar